GLP1R and obesity due to melanocortin 4 receptor deficiency: Overall, the favorable metabolic profile induced by GLP-1 RAs (weight loss and reduced caloric intake, improvement in glycemic compensation) allows one to hypothesize their potential effectiveness in the treatment of NAFLD, in addition to T2DM and obesity.